Target intelligence / Profile preview

RHOG family member 2, pseudogene (RHOG2P)

Target: RHOG2P
Molecular classification: Other (Pseudogene)

Overview

RHOG family member 2, pseudogene (RHOG2P), is a genomic DNA locus annotated as a pseudogene—meaning it resembles the functional RHOG gene but does not produce a functional protein or have known biological activity[3]. Pseudogenes are often remnants of gene duplication or retrotransposition events and typically lack coding potential due to accumulated mutations. RHOG2P is not considered a therapeutic target (such as a receptor, enzyme, transporter, etc.) and has no experimentally validated function, disease association, or drug interaction. This differentiates it from its functional counterpart RHOG, which is involved in actin cytoskeleton reorganization and immune cell migration[1][2].

Other names: ras homolog family member G pseudogeneRHOG2P

Beyond the preview

Go deeper on RHOG family member 2, pseudogene (RHOG2P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on RHOG family member 2, pseudogene (RHOG2P).

Explore the full profile